FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

3209011000001109: Nuvelle TS Phase I patches (Schering Health Care Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17416101000001110 Nuvelle TS Phase I patches (Schering Health Care Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
44855501000001118 Nuvelle TS Phase I patches (Bayer Plc) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Nuvelle TS Phase I patches (Schering Health Care Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Nuvelle TS Phase I patches (Schering Health Care Ltd) Is a Estradiol 80micrograms patch false Inferred relationship Existential restriction modifier
Nuvelle TS Phase I patches (Schering Health Care Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Nuvelle TS Phase I patches (Schering Health Care Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Nuvelle TS Phase I patches (Schering Health Care Ltd) Has active ingredient Estradiol true Inferred relationship Existential restriction modifier
Nuvelle TS Phase I patches (Schering Health Care Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Nuvelle TS Phase I patches (Schering Health Care Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Nuvelle TS Phase I patches (Schering Health Care Ltd) Has manufactured dose form Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
Nuvelle TS Phase I patches (Schering Health Care Ltd) Is a Nuvelle TS Phase I true Inferred relationship Existential restriction modifier
Nuvelle TS Phase I patches (Schering Health Care Ltd) Has specific active ingredient Estradiol true Inferred relationship Existential restriction modifier
Nuvelle TS Phase I patches (Schering Health Care Ltd) Has dispensed dose form Prolonged-release transdermal patch true Inferred relationship Existential restriction modifier
Nuvelle TS Phase I patches (Schering Health Care Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Nuvelle TS Phase I patches (Schering Health Care Ltd) Is a Estradiol 80micrograms/24hours transdermal patches false Inferred relationship Existential restriction modifier
Nuvelle TS Phase I patches (Schering Health Care Ltd) Is a Estradiol 80micrograms/24hours transdermal patches true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Nuvelle TS Phase I patches (Schering Health Care Ltd) 4 patch Is pack of False Nuvelle TS Phase I patches (Schering Health Care Ltd) Inferred relationship Existential restriction modifier
Nuvelle TS Phase I patches (Schering Health Care Ltd) 4 patch Has AMP True Nuvelle TS Phase I patches (Schering Health Care Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start